Welcome Petros Apostolopoulos, DISPENDIX’S new CEO!
We are excited and proud to announce the appointment of Petros Apostolopoulos as our new CEO. Effective from 2nd August 2021, Petros will take over operations from Harry Böltz.
In 2016, DISPENDIX started as a spin-off from the Fraunhofer Institute for Manufacturing Engineering and Automation in Stuttgart, Germany. With only two people, who built this great company with the vision to establish a new innovative technology in non-contact liquid handling which is affordable for everyone. Today, we have a global customer base and generate millions in sales. Harry Böltz, one of the founders, knew the demand for this kind of technology will grow and providing a flexible, fast, and reliable product would be the solution for many laboratories.
Petros brings a wealth of experience and abilities which will be tremendously beneficial for DISPENDIX and will forward our progress. With over 15 years of experience in life sciences and industrial automation, his direction and organization are assets that will improve the productivity of the team.
Petros will lead our product, growth, market expansion and overall business operations. He will drive our strategy and focus on our customers success and build the best team and culture in our industry.
‘I am thrilled to be joining the dynamic and talented DISPENDIX team in Stuttgart. With the groundbreaking drop-on-demand technology, DISPENDIX has already set new standards in low volume dispensing. Building on this, we would like to enter the next growth phase and scale the company in line with sales growth.
With new liquid handling technologies for the scientific community, we will work with our customers to create the Future of Medicine. This will enable life-saving diagnoses to be made more quickly and new discoveries to be achieved in the fields of drug discovery and personalized healthcare.’
Alongside our leadership team at CELLINK and CYTENA, Petros will grow our ecosystem across the globe and our mission to and make an impact by creating the future of medicine by engineering science.
We are ready for what is next! Welcome aboard!
To view full press release, please visit here.